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Indomethacin enhancement of glycerol-induced acute renal
failure in rabbits
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Indomethacin enhancement of glycerol-induced acute renal
failure in rabbits. Seventy-three rabbits (2 to 3 kg in weight) were
studied during a control period and after receiving 5O% glycerol
(U) or mercuric chloride (M) with or without indomethacin (I)
(controls received the diluent used for I). Plasma creatinine,
plasma renin activity, blood pressure, sodium and potassium
concentrations, hematocrit value, urinary output, body wt and
histologic appearance of the kidney were determined. I enhanced
the incidence and severity of the acute renal failure produced by
U but failed to aggravate that produced by M. Because the dose
of I used in this study blocked the synthesis of renal prostaglan-
dins in the rabbit, we suggest that renal prostaglandins protect
against the development of U-induced acute renal failure (a
circulatory type of renal failure) in this animal model. Further-
more, the failure of Ito aggravate M-indueed acute renal failure
indicates that it is unlikely that I aggravates U-induced acute
renal failure by a direct nephrotoxie effect. No evidence was
found for other possible side actions of I being responsible for the
observed aggravation.
Augmentation par l'indométhacine de l'incidence et de Ia
sévérité de l'insuttlsance rénale induite par le glycErol chez le lapin.
Soixante treize lapins (2 a 3 kg) ont Eté étudiés durant une période
eontrôle et aprEs avoir recu du glycerol a 5O% (U) ou du ehlo-
rure mereurique (M) avee ou sans indométhacine (I) (les eon-
troles ont reçu le solvant de I). La eréatinine plasmatique, l'aeti-
vitE rEnine plasmatique, la pression artErielle, les concentrations
de sodium et de potassium, l'hématocrite, le dEbit urinaire ont
Eté dEterminEs et l'aspect histologique du rein a EtC EtudiE. L'in-
domEthaeine augmente l'incidenee et la sévErité de l'insuffisanee
rEnale aiguë produite par U mais n'aggrave pas eelle produite
par M. Du fait que Ia dose del utilisée bloque Ia synthEse rEnale
des prostaglandines chez le lapin nous suggErons que les prosta-
glandines rEnales protEgent du dEveloppement de l'insuffisance
rénale aigub induite par G (qui est un modEle d'insuffisance
rénale d'origine eireulatoire). De sureroit, le fait que I n'aggrave
pas l'insuffisance rEnale induite par M rend improbable uneaggra-
vation de l'insuffisanee rénale aiguë du glycerol par un méean-
isme nEphrotoxique direct. Aueun argument n'a étE obtenu en
faveur d'autres effets seeondaires possibles de I qui pourraient
Etre responsables de l'aggravation observEe.
Acute renal failure (acute tubular necrosis), a syn-
drome initiated by an ischemic or toxic injury to the
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kidney, is characterized by a sudden cessation of renal
function. A sustained depression of the glomerular
filtration rate, probably due to constriction of the
afferent arterioles, is the factor now generally thought
to best explain the pathogenesis of acute renal failure
in many experimental models [1]. Angiotensin and
norepinephrine are the vasoactive agents most often
considered important in the initiation or maintenance
of this vasoconstriction [2]. It is known that in some
animal species prostaglandin E (PGE) opposes the
vasoconstrictor actions of angiotensin and norepine-
phrine [3] and modulates the release of neurotrans-
mitter [4]. Furthermore, PGE is released at the time
when the vasoconstriction produced by the infusion of
angiotensin or norepinephrine into the kidney is re-
versed [3]. It is possible that release of PGE acts in a
feedback mechanism by which renal vasoconstrictor
actions could be modified [3].
Therefore, it would seem reasonable to postulate
that a defect or alteration in the synthesis of prosta-
glandins in the kidney might play a role in the develop-
ment or maintenance of acute renal failure [5]. If this
were the case, then blockade of prostaglandin syn-
thesis should result in an increase in the severity or the
incidence of experimentally induced acute renal failure.
The aim of this study was to test this hypothesis.
The experimental models of glycerol-induced and
mercuric chloride-induced acute renal failure were
selected for evaluation because they have been studied
extensively and they are representative of two different
types of injury—circulatory and nephrotoxic types, re-
spectively.
Methods
Effect of indomethacin on development of glycerol-
induced acute renal failure. 1) Groups treated with low
dose of glycerol. Fourteen New Zealand male rabbits
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(2 to 3 kg), fed a standard laboratory diet and water
ad lib, were divided into two groups (g and gI),
weighed and kept in cages especially designed for
urine collection. Twenty-four hours later, 4 ml of
blood was drawn—2 ml into chilled tubes (Vacutainer)
containing 0.05 ml of 7.5% EDTA K3 for plasma renin
activity (PRA) determination and 2 ml into hepar-
inized tubes (Vacutainer) for determinations of plasma
creatinine and electrolyte concentrations. Then, indo-
methacin suspended in phosphate buffer (40 mg/mi;
pH 8.0) was injected into the marginal vein of the ear
of rabbits of group gI (8 mg/kg; total volume, 0.2 ml/
kg); group g received an i.v. dose of phosphate buffer
alone (0.2 ml/kg). Half an hour later, both groups
were given 50% glycerol in isotonic saline (10 ml/kg)
by injection into the loose subcutaneous tissue behind
the neck (under light ether anesthesia). Two and six
hours after glycerol injection, indomethacin suspended
in sesame oil (80 mg/mI) was injected subcutaneously
into the rabbits of group gI (8 mg/kg; total volume,
0.1 ml/kg); sesame oil alone (0.1 ml/kg) was injected
into rabbits of group g. Blood samples for measure-
ments of PRA, plasma creatinine and electrolytes were
collected again 24, 48 and 72 hr after glycerol injection,
and urinary output and body wt were determined every
24 hr.
2) Groups treated with high dose of glycerol. Four-
teen rabbits were divided into two groups (GI and G).
Group GI received glycerol (14 ml/kg) and indome-
thacin (total dose: 24 mg/kg in three doses as already
described herein). Group G received glycerol alone
plus the diluent used for indomethacin. The protocol
was similar to that described for the low-dose ad-
ministration of glycerol, except that measurements of
arterial hematocrit were obtained and the observations
were terminated after 24 hr. At that time, the rabbits
were killed, the left kidney was removed and a thin
wedge (2 mm) of renal tissue, including cortex, med-
ulla and papilla, was fixed in Helly's solution. Observa-
tions on renal morphology were obtained in seven
rabbits from group GI and five from group G.
Effect of indomethacin alone on plasma creatinine
concentration and PRA. Six rabbits (group I) were
given an i.v. dose of indomethacin (8 mg/kg; total
volume, 0.2 mi/kg) suspended in phosphate buffer
(40 mg/mi) and two subcutaneous doses of indometha-
cm (8 mg/kg) suspended in sesame oil (80 mg/mi) 24-
and 64- hr later. Twenty-four hours after the first in-
jection of indomethacin, blood samples were collected
for measurement of PRA and plasma creatinine and
electrolyte concentrations. Twenty-four-hour urinary
output was measured. Then, four rabbits were killed,
the left kidney was removed, and a thin (2 mm) wedge
of tissue including cortex, medulla and papilla was
fixed in Helly's solution for study of renal patho-
logy.
Effect of indomethacin on blood pressure and PRA
after the administration of glycerol. Nine New Zealand
male rabbits (2 to 3 kg), fed a standard laboratory diet
(Wayne rabbit ration) and water ad Jib, were randomly
divided into two groups. Five rabbits were injected
with three sequential doses of indomethacin as out-
lined; four were treated with diluent alone. Both
groups were given a single subcutaneous dose of 50%
glycerol (14 ml/kg) 30 mm after the initial i.v. dose of
indomethacin. During a control period prior to i.v.
administration of indomethacin and at 6 and 24 hr
after glycerol administration, arterial blood pressure
was measured and recorded directly on a polygraph
(Grass) via direct cannulation of the central artery of
the ear with a 21-gauge butterfly needle connected to
a pressure transducer (Statham P23). PRA was deter-
mined in blood samples (2 to 3 ml) drawn from the
central artery of the ear into chilled tubes (Vacutainer)
containing 0.05 ml of 7.5% EDTA K3 prior to indo-
methacin administration and at 6 and 24 hr after gly-
cerol administration.
Effect of indoinethacin on development of mercuric
chloride-induced acute renal failure. Fourteen rabbits
were divided into two groups (MI and M). Group MI
received mercuric chloride (4 mg/kg, 30 mm after the
first dose of indomethacin) and indomethacin (24 mgI
kg, divided into three doses as already outlined herein).
Group M received mercuric chloride and indomethacin
diluent. The experimental protocol was identical to
that followed in the groups that were treated with low-
dose glycerol, with the exception that a solution of
mercuric chloride in isotonic saline (1 mg/mi) was in-
jected instead of glycerol into the loose subcutaneous
tissue behind the neck.
Effect of indomethacin on renal synthesis of prosta-
glandins. The kidneys from eight normal New Zealand
male rabbits and eight rabbits treated with indometha-
cm (18 mg/kg in two doses, six and four hours before)
were rapidly removed and cut through the hilus into
two equal portions; one-half was immediately im-
mersed in liquid nitrogen (elapsed time, 6 to 15 sec)
and the other one-half was kept at room temperature
for ten minutes before being frozen in the same manner.
The effect of indomethacin was assessed by compar-
ing the ratios of prostaglandin (PG) concentrations,
incubated one-half/nonincubated one-half, in whole
kidney tissue from normal rabbits and indomethacin-
treated animals, on the basis that the postremoval
accumulation of PG in renal tissue [6] is presumably
due to the relative preservation of medullary synthesis
with parallel impairment of PG transport from the site
of production.
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Chemical and histologic methods. PRA was measured
by the radioimmunoassay method of Haber et a! [7].
Reagents were purchased from E. R. Squibb and Son,
Princeton, NJ (angiotensin I Immunotope kit). Angio-
tensinases were inhibited by the addition of ethylene-
diaminetetraacetic acid (EDTA), 8-hydroxyquinoline
and 2,3-dimercapto-1-propanol. After one hour of in-
cubation, the amount of angiotensin formed per milli-
liter of plasma was estimated by radioimmunoassay in
duplicate on four different dilutions of the incubated
plasma. The results were expressed in nanograms of
angiotensin I generated in 1 ml of plasma per hour
(ng x m1' x hr-'). On replicate determinations on
three individual samples, the mean values were 13.67
(N=75), 13.35 (N= 36) and 16.57 (N=21) ng' x
hr' with coefficients of variation of 11.8, 10.4 and
11 .8%, respectively.
Renal tissue prostaglandins E (PGE) were measured
by radioimmunoassay. Reagents were purchased from
Clinical Assays, Inc. After extraction from the kidney
with 95% ethanol, PGE were separated by silicic acid
column chromatography [8] and converted to PGB by
alkaline treatment [9]. PGB was then measured by
comparison of its inhibitory effect on the binding of
[3H}PGB1 to anti-PGB1 antibody with the inhibitory
effect of known amounts of unlabeled PGB2. Unlabeled
PGB2 was used instead of PGB1 because the naturally
occurring PGE in the kidney is PGE2 [3]. Each sample
was run in duplicate. Recoveries of exogenous PGE
(600 to 800 cprn) through the extraction and column
chromatography were determined for each sample, and
individual correction factors were introduced accord-
ing to these recoveries (range, 30 to 80%). Quantitative
conversion (90 to 100%) of PGE to PGB is obtained
by the alkaline treatment. Results were expressed in
nanograms of PGE2-equivalent per gram of tissue.
The plasma creatinine concentration was measured
by a modified picric acid method [10]. A micromethod
was used for hematocrit determination.
After paraffin embedding of fixed renal tissue, 4-
mole sections were stained with hematoxylin-eosin
and periodic acid-Schiff stains. The sections were ex-
amined on a blinded basis and graded according to
1) the degree of coagulative necrosis and vacuolar
hydropic degeneration (on a scale from 0 to 4), 2) the
number of casts and dilated tubules (from 0 to 4) and
3) the degree of interstitial edema (from 0 to 2). The
final score was represented by the sum of these grades
and was considered to reflect a semiquantitative esti-
mate of morphologic impairment.
Statistical analysis. The Wilcoxon sign rank test was
used to test significance of changes with time within
each group. Due to the unequal variance of the various
groups, treatment differences were analyzed by a rank
sum test [11], which is a conservative, nonparametric
procedure, instead of by the two-sample t test. Because
control paired values were not obtained in the groups
treated with the high dose of glycerol, control values of
the other groups were used in their place and the signif-
icance of the differences between these unpaired ob-
servations was tested by the rank sum test. In the text
and in the figures, the data are shown as mean SD.
Results
Effect of indomethacin on development of glycerol-
induced acute renalfailure. a) With low dose of glycerol.
A significant (P <0.02) increase in plasma creatinine
concentration was observed at 24 hr in group gI
(Fig. 1); a significant change was not observed at 24 hr
in group g (P >0.05). The plasma creatinine concentra-
tions at 48hr (g=1.37±0.69mg/lOOml; gI=4.12±
3.44; P<0.04) and 72 hr (g=1.40± 1.14; gI=4.78±
4.77; P<0.03) were equivalent to those observed at
24 hr.
Mean urinary outputs did not change significantly
(P>0.05) but, when values after glycerol treatment
from individual animals were compared to those of the
control period, a marked decrease was found in three
of the rabbits in group gi and in none in group g
(Fig. 2). No change in body wt was detected at 24 hr
(g=2.60±0.55 kg; gI=2.61 0.39 kg) as compared to
the control values (g=2.60±0.48 kg; gI=2.62±
24hr
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Fig. 1. Plasma creatinine concentrations in control period and at
24 hr after administration of glycerol (g= low dose; G=high dose)
or mercuric chloride (M) with or without indomethacin I). Rec-
tangles represent mean and SD. Hatched areas represent range of
values recorded in control period in that group of animals.
P values between columns refer to differences between groups
represented by columns; * values in columns refer to differences
between values represented in columns and those obtained in
control period (hatched areas) or total control observations.
Acute renal failure enhanced by indomethacin 173
Urine volume
0.36 kg). A slight but nonsignificant decrease in body
wt was observed in both groups at 48 hr (g=2.56
0.51 kg; gI=2.49±0.41 kg) and 72hr (g—2.53±
0.47 kg; gI=2.46±0.38 kg).
In both g and gi, PRA was lower at 24, 48 and 72 hr
than in the control period (Fig. 3). There was no signi-
ficant difference between values for PRA from these
two groups at 24, 48(g=12.8±4.9ngxml'x
hr; gi = 9.6 7.3 ng x ml 'x hr) and 72 hr (g
8.8 5.3ngx m1' x hr'; gI=12.5± 17.9ngx m11 x
hr').
No significant differences between g and gi were
found for plasma sodium or potassium concentration.
b) With high dose of glycerol. At 24 hr there was a
significant increase in plasma creatinine concentration
in groups G and GI compared to the control values
(Fig. 1). The plasma creatinine concentration was sig-
nificantly (P <0.01) higher in the group treated with
glycerol and indomethacin (GI) than in the groups in-
jected with glycerol alone (G).
Urine volume (Fig. 2) during the 24 hr after the ad-
ministration of glycerol was significantly decreased in
group GI as compared to either the control values
(P < 0.01) or to values at 24 hr in group G (P<0.01).
No significant change was observed in groups G and I.
Mean PRA at 24 hr in group GI was significantly
decreased compared to the control values (P < 0.04);
there was a nonsignificant increase in group G (Fig. 3).
The difference between mean PRA values for groups G
and GI was of borderline significance (P =0.07).
For group GI, the mean plasma sodium concentra-
tion (131 3 mEq/liter) was significantly less (P <0.05)
and the mean plasma potassium concentration (6.4
1.5 mEq/liter) was significantly greater (P <0.05) than
for group G (136± 5 and 4.5± 1.1 mEq/liter). No sig-
nificant changes of hematocrit values were found
between group G and group GI (32 5% vs. 33± 5%).
The more prominent pathologic findings at 24 hr
after administration of glycerol included 1) coagulative
necrosis and vacuolar hydropic degeneration affecting
mainly the proximal convoluted tubules; 2) casts,
primarily located in the distal convoluted tubules and
Henle's loop; and 3) variable degrees of tubular dilata-
tion and interstitial edema. The morphologic change
observed in the rabbits treated with indomethacin and
glycerol, with a mean (±SD) lesion grade of 7.1 1.1,
was significantly more pronounced (P <0.05) than that
found in rabbits treated with glycerol alone (grade,
4.2 2.4).
Effect of indomethacin on plasma creatinine con-
centration and PRA. No significant differences in
plasma creatinine concentration (Fig. 1) or urine
volume were observed in group I when compared with
the control group during the 24 hr after administration
of indomethacin (Fig. 2). Mean PRA (Fig. 3) was sig-
nificantly decreased (P <0.01). The renal tissue from
this group was histologically normal.
Effect of indomethacin on blood pressure and PRA
after administration of glycerol. No significant changes
in systolic or diastolic blood pressure were observed at
6 and 24 hr after the administration of glycerol (14 mu
Fig. 2. Twenty-four-hour urine volumes before and after ad-
ministration of glycerol (g=low dose; G=high dose) or mercuric
chloride (M) with or without indomethacin (I). Rectangles repre-
sent mean and SD. Hatched areas represent range of values
recorded at control period in that group of animals. P values
between two columns refer to differences between groups repre-
sented by columns; * values in columns refer to differences
between values represented in columns and those obtained in con-
trol period (hatched areas) or total control observations.
Fig. 3. Plasma renin activity in control period and at 24 hr after
administration of glycerol (g low dose; G = high dose) or mer-
curic chloride (M) with or without indomethacin (I). Rectangles
represent mean and SD. Hatched areas represent range of values
recorded in control period in that group of animals. P values
between columns refer to differences between groups represented
by columns; * values in columns refer to differences between
values represented in columns and those obtained in control
period (hatched areas) or total control observations.
174 Torres et al
plasma creatinine concentration, 6.85 1.3 mg/lOOml;
PRA, 17.4± 9.6 ngxml'xhr'; and urine volume,
29 47 ml/24 hr (17.8% of control value). In group MI
they were as follows: plasma creatinine concentration,
7.31± 1.4 mg/100 ml; PRA, 32.8±38.4 ngxml'x
hr'; and urine volume, 29±47 ml/24 hr (14.6% of
control value). A nonsignificant decrease in body wt
was observed in group M (control=2.81 0.36 kg;
24 hr= 2.76 0.39 kg; 48 hr=2.71 0.34 kg) and group
MI (control=2.64±0.38 kg; 24 hr=2.55±0.38 kg;
48 hr==2.55±0.49 kg).
Effect of indomethacin on renal synthesis of prosta-
glandins. In the portion of kidney that was frozen im-
mediately after removal, the PG content was signif-
icantly lower (P<0.001) in the rabbits treated with
indomethacin than in the rabbits that received only
diluent (Fig. 5). The accumulation of PG in the renal
tissue during ten-minute incubation at room temper-
ature (in controls, incubated one-half/nonincubated
one-half= 8.2 2.2 [SE]) was almost completely blocked
in the indomethacin-treated rabbits (ratio 1.6±0.2).
From these ratios, the degree of inhibition by this par-
ticular dose of indomethacin was estimated to be
approximately 80%.
Discussion
kg), with or without simultaneous administration of
indomethacin (Fig. 4). PRA values at 6 and 24 hr were
higher than in the control period in all animals in-
jected with glycerol alone, but this increase was not
observed in the animals injected with glycerol and in-
domethacin; the difference at 6 hr was statistically
significant (P <0.02).
Effect of indomethacin on development of mercuric
chloride-induced acute renal failure. A significant in-
crease in plasma creatinine concentration and a signif-
icant decrease in urine volume were observed in
groups M and MI at 24 (Fig. 1 and 2), 48 and 72 hr;
PRA did not change significantly (Fig. 3). No signif-
icant differences were found between group M and
group MI. Three of the animals of group MI died
between 48 and 72 hr after the administration of mer-
curic chloride, and, therefore, values at 72 hr are not
reported.
At 48 hr the values in group M were as follows:
Fig. 5. Effects of indomethacin treatment on renal prostaglandin
E (PGE)concentration.
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Fig. 4. Mean (± SD) arterialblood pressure (BP) andpiasma renin plus indomethacin than in the rabbits treated with
activity (PRA) after treatment with 5Q% glycerol (14 mi/kg) with glycerol alone. Changes in the plasma creatinine(N= 5) or without (N= 4) indomethacin.
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concentration during acute renal failure reflect changes
in glomerular filtration rate more accurately than do
changes in the blood urea nitrogen concentration [12].
A false increase in the plasma creatinine concentration
could occur due to the muscle necrosis that intra-
muscular injection would produce, but we injected into
the subcutaneous tissue to avoid this. The possibility
that indomethacin could interfere with the determina-
tion of plasma creatinine was ruled out by replicate
determinations on an individual sample to which
different amounts of indomethacin plus diluent or
diluent alone were added. Furthermore, the possibility
that indomethacin alone could have any effect on
creatinine production seems unlikely since we did not
detect any effect of indomethacin treatment on the in-
crease of plasma creatinine concentration after bine-
phrectomy in rats.
Whether the aggravation of glycerol-induced acute
renal failure was due to the blockade of the renal syn-
thesis of PG produced by indomethacin or to some
other nonspecific effect of this drug cannot be de-
finitely settled on the basis of the present data.
Possible actions of indomethacin not related to
blockade of prostaglandin synthesis. Actions of indo-
methacin that may be unrelated to blockade of prosta-
glandin synthesis might be responsible for aggravation
of glycerol-induced acute renal failure in this model and
should be ruled out by using another inhibitor of PG
synthesis (ideally, unrelated to aspirin-like substances).
Nevertheless, analysis of the known possible mecha-
nisms by which indomethacin might modify the devel-
opment of glycerol-induced acute renal failure other
than blockade of the synthesis of renal PG does not
provide a convincing explanation for the observed
aggravation.
1) It is known that indomethacin inhibits cyclic
nucleotide phosphodiesterase, being ten times more
effective as an inhibitor than theophylline on a molar
basis [13, 14]. This inhibition would result in an intra-
cellular accumulation of adenosine cyclic 3', 5'-mono-
phosphate (cyclic AMP). Cyclic AMP has been shown
to produce renin release [15] and probably is the medi-
ator for renin release by different agents such as
theophylline and adrenergic drugs. If this is true,
aggravation of acute renal failure by indomethacin
could be explained by enhanced secretion of renin.
However, our results show that the PRA values of the
animals treated with indomethacin and glycerol were
not different from or were lower than the PRA values
of the rabbits treated with glycerol alone and that indo-
methacin treatment blocked the increase of PRA ob-
served at six hours after glycerol administration. This
tendency, in the indomethacin-treated rabbits, to ex-
hibit low PRA values is in agreement with our previous
observation [16] that i.v. administration of this drug to
normal or to renal hypertensive rabbits is followed by
a significant decrease in PRA. From our data, it is
difficult to ascribe an important contributory role to
renin in the aggravation of acute renal failure produced
by indomethacin. However, since PRA does not neces-
sarily reflect the intrarenal activity of the renin-angio-
tensin system in acute renal failure, possible effects on
the intrarenal renin mechanisms of indomethacin can-
not be evaluated on the basis of our experiments.
2) It has been found that PG inhibit the release of
catecholamines and dopamine /3-hydroxylase induced
by nerve stimulation [4]. From these observations it
has been proposed that PG might play an important
role in modulating sympathetic activity, acting as an
adrenergic brake. In rats the i.m. administration of
glycerol results in a marked decrease in blood volume
[17], while blood pressure is maintained, probably due
to an adrenergic response. It therefore could be specu-
lated that in our experiments the blockade of the PG
adrenergic brake system could lead to excessive ische-
mia of vascular territories other than the kidney, with
a subsequent production of irreversible lesions or he-
modynamic collapse. However, this possibility seems
unlikely since no macroscopic lesions other than those
inherent to this particular model of renal failure were
found and no indication of circulatory collapse was
present.
3) It has been reported [18] that high doses of
aspirin produce cortical tubular necrosis in the rat. In
our study, necrotic tubular lesions were not detected
by light microscopy in the rabbits treated with indo-
methacin alone. The absence of these lesions does not
completely exclude the possibility that indomethacin
had enhanced glycerol-induced acute renal failure by a
direct tubular toxic effect. Nevertheless, the fact that
indomethacin did not aggravate mercuric chloride-
induced acute renal failure renders this possibility un-
likely.
4) It is known that dehydration strongly potentiates
the development of glycerol-induced acute renal failure.
We cannot entirely disprove, with our data, that the
aggravation produced by indomethacin could be due
to a negative fluid balance. Nevertheless, the fact that
no changes in body wt were detected at 24 hr after the
administration of glycerol alone or glycerol plus in-
domethacin, when the major changes in plasma creat-
mine were already observed, does not support this
possibility. Furthermore, in the rabbits killed at 24 hr
we did not find any gross evidence of fluid sequestra-
tion in a third space that also could explain the ag-
gravation of glycerol-induced acute renal failure.
5) The lack of significant difference between the
hematocrit values of glycerol-treated rabbits with and
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without indomethacin shows that the protective action
of indomethacin against osmotic hemolysis, proved in
vitro [19], did not influence our experiment.
Possible actions of indomethacin related to blockade
of PG synthesis. Increased total renal vascular resis-
tance and, possibly, intrarenal redistribution of blood
flow to the inner cortex [20,21] occur in response to
such stimuli as hemorrhage, low sodium intake, volume
contraction and intrarenal infusion of angiotensin or
norepinephrine. These hemodynamic alterations are
rapidly reversed when the causative stimuli are removed.
In extreme situations, these stimuli can predispose to
or even cause acute renal failure. Once acute renal
failure has developed, the intrarenal hemodynamic
alterations are not so rapidly reversible and seem to be
maintained by a mechanism still to be elucidated
[22].
It has been proposed that angiotensin or some other
vasoconstrictor factor can be the mediator of the he-
modynamic changes outlined. PGE2 infusion into the
renal artery reverses the intrarenal hemodynamic
changes produced by angiotensin II or norepinephrine
[3]. Furthermore, PGE2 is released from the kidney in
response to intrarenal infusion of angiotensin H or
norepinephrine [3]. It has been postulated that renal
PGE2 may play an important physiologic role in pro-
tecting the kidney against the excessive influence of the
vasoconstrictor agents [3].
It therefore seems possible that the relative capacity
for renal PG synthesis could determine the threshold
beyond which factors tending to cause ischemic insult
to the kidney could produce acute renal failure. The
fact that indomethacin treatment enhanced both the
incidence and the severity of glycerol-induced acute
renal failure in the rabbit is consistent with this
hypothesis, since the dose of indomethacin used in
this study has been proved to inhibit markedly the
renal synthesis of PG.
The dose of indometbacin was calculated from pub-
lished data [23] indicating good inhibition of PG syn-
thesis. To ensure that such a dose was effective in
blocking PG synthesis, we studied the in vitro rate of
formation of PG in kidneys from rabbits before and
four hours after treatment with indomethacin. This ex-
periment was based on the results published by
Anggârd et al [6], who found that the PG concentra-
tion in excised kidney allowed to remain at room tem-
perature was much higher than the PG concentration
found in portions of the same kidney frozen immedi-
ately in liquid nitrogen. The demonstration of signifi-
cantly lower basal PG concentrations in the kidneys of
the indomethacin-treated rabbits, along with the al-
most complete suppression of the PG accumulation
during room temperature incubation, proves that renal
PG synthesis is markedly inhibited for at least four
hours after the administration of a dose of indometha-
cm similar to that used in the other experiments.
There remains at least one conceptual difficulty:
How may inhibition of medullary PG synthesis affect
cortical hemodynamics? Itskovitz, Terragno and
McGiff [24] postulated that medullary PGE2 may in-
fluence inner cortical blood flow by virtue of the rela-
tionship whereby the efferent arterioles of the inner
cortex, but not those of the outer cortex, extend into
the medulla and give rise to the vasa recta. Other possi-
bilities exist because it has not been definitely estab-
lished that there is no PG synthesis in the cortex
[25].
Model and species spec jficity. In contrast to the
aggravation of glycerol-induced acute renal failure pro-
duced by indomethacin, no significant differences were
observed between the groups of rabbits treated with
mercuric chloride and with mercuric chloride and indo-
methacin. The disparity of the effects of indomethacin
treatment on glycerol- and mercuric chloride-induced
acute renal failure deserves special comment, because
similar pathophysiologic changes have been described
[1, 2] as being responsible for the maintained depres-
sion of renal function in these models. This suggests
that indomethacin probably exerts its effects on a phase
in the pathogenesis of acute renal failure that is not
shared by both models. It is known, for example, that,
in the rat, renal vasoconstriction is a very early altera-
tion observed after i.m. administration of glycerol [26],
whereas capillary circulation in kidney surface is
grossly normal for the first six hours after the injection
of mercuric chloride [27]. If this is true in the rabbit,
then the enhancement of glycerol-induced acute renal
failure by indomethacin could be explained by a poten-
tiation of the initial vasoconstriction due to the block-
ade of PG synthesis. On the other hand, the possibility
that indomethacin could limit the access to (by decreas-
ing renal blood flow) or the action of mercuric chloride
on the renal tubular cells, which seems to be the initial
event in the pathogenesis of mercuric chloride-induced
acute renal failure, deserves further study.
Special consideration has to be paid to the fact that
the administration of an identical dose of indometha-
cm to the rat does not result in an aggravation of
glycerol-induced acute renal failure in this animal (un-
published data). The reason for this difference in be-
havior between these two species is not clear. How-
ever, a recent report [28] has shown that PGE and in-
domethacin cause changes in vascular resistance and
adrenergic transmission in the isolated kidney of the
rat that are markedly different from those observed in
other animal species, such as the rabbit [28] or the dog
[29]. In these animals administration of PGE results in
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renal vasodilatation and of indomethacin results in
renal vasoconstriction. Therefore, the difference in
effects of indomethacin treatment on the development
of glycerol-induced acute renal failure in the rabbit and
in the rat favors our point of view that the aggravation
observed in the rabbit is due to the blockade of PG
synthesis. The demonstration of indomethacin-induced
enhancement of glycerol-induced acute renal failure in
rabbits but not in rats (and the absence of this phenom-
enon in the mercuric chloride model in both species)
might suggest that the pathogenetic implications of
this observation are of limited importance and that
they may not apply to other models of acute renal
failure, including that of man. However, these ob-
servations may also serve to reflect the very diversity
of the mechanisms that may be operative in acute renal
failure and underscore the oft-forgotten fact that
mechanistic observations in one species cannot always
be applied to other species, even when the inciting
cause seems to be identical.
Conclusions. The results of this study are in agree-
ment with the prevailing concept that PG play an im-
portant physiologic role in the maintenance of renal
circulatory homeostasis in some animal species. Cir-
cumstantial evidence has been presented here that
renal PG may protect against the development of a
circulatory type of acute renal failure in the rabbit.
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